OS in all DLBCL
Clinical features . | P4HA2 expression . | MST (95% CI) . | Log-rank P . |
---|---|---|---|
≤54 y old | .201 | ||
Low | |||
High | 42.0 | ||
>54 y old | .598 | ||
Low | 77.1 (61.0-93.2) | ||
High | |||
Male | .921 | ||
Low | 70.3 (49.4-91.2) | ||
High | |||
Female | .052 | ||
Low | |||
High | 42.0 (4.1-79.9) | ||
Non-GCB | .042 | ||
Low | 70.3 (63.1-77.5) | ||
High | |||
GCB | .820 | ||
Low | |||
High | 40.1 (15.9-64.3) | ||
IPI low (0-1) | .317 | ||
n = 53 | Low | ||
High | |||
IPI high (2-5) | .521 | ||
n = 44 | Low | 46.8 | |
High | 20.7 | ||
CHOP | .039 | ||
n = 55 | Low | 70.3 | |
High | 26.2 | ||
R-CHOP | .529 | ||
n = 27 | Low | ||
High | |||
CHOP/R-CHOP | .033 | ||
n = 82 | Low | 77.1 | |
High | 44.1 |
Clinical features . | P4HA2 expression . | MST (95% CI) . | Log-rank P . |
---|---|---|---|
≤54 y old | .201 | ||
Low | |||
High | 42.0 | ||
>54 y old | .598 | ||
Low | 77.1 (61.0-93.2) | ||
High | |||
Male | .921 | ||
Low | 70.3 (49.4-91.2) | ||
High | |||
Female | .052 | ||
Low | |||
High | 42.0 (4.1-79.9) | ||
Non-GCB | .042 | ||
Low | 70.3 (63.1-77.5) | ||
High | |||
GCB | .820 | ||
Low | |||
High | 40.1 (15.9-64.3) | ||
IPI low (0-1) | .317 | ||
n = 53 | Low | ||
High | |||
IPI high (2-5) | .521 | ||
n = 44 | Low | 46.8 | |
High | 20.7 | ||
CHOP | .039 | ||
n = 55 | Low | 70.3 | |
High | 26.2 | ||
R-CHOP | .529 | ||
n = 27 | Low | ||
High | |||
CHOP/R-CHOP | .033 | ||
n = 82 | Low | 77.1 | |
High | 44.1 |
Bold P values represent significant difference.
CI, confidence interval; MST, mean survival time.